V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270012715 | 270008242 | 1.65 | 83.3 | Curative (C) | 2014-09-09 | 2016-04-02 | Brentuximab | 02 | N | 270012259 | BRENTUXIMAB |
| 270012716 | 270008244 | null | null | Neo-adjuvant (N) | 2018-02-23 | 2018-02-23 | Capecitabine + Oxaliplatin 21day | 2 | N | 270012260 | CAPECITABINE + OXALIPLATIN |
| 270012717 | 270008245 | 1.54 | 63.7 | Adjuvant (A) | 2014-02-28 | 2014-03-08 | Brentuximab | 2 | N | 270012264 | BRENTUXIMAB |
| 270012718 | 270008247 | 1.89 | null | Adjuvant (A) | 2017-12-27 | 2017-12-31 | CAPECITABINE + OXALIPLATIN | N | N | 270012265 | CAPECITABINE + OXALIPLATIN |
| 270012719 | 270013918 | null | 70.9 | Palliative (P) | 2014-10-09 | 2014-11-10 | Capecitabine + Oxaliplatin 21day | null | null | 270012265 | CAPECITABINE + OXALIPLATIN |
| 270012720 | 270013918 | 1.75 | 51.8 | Curative (C) | 2014-09-08 | 2014-09-22 | COPP + Dacarbazine | N | N | 270012265 | COPP + DACARBAZINE |
| 270012721 | 270019882 | 1.78 | 38.4 | Curative (C) | 2016-11-18 | 2016-11-30 | Escalated BEACOPP | 02 | N | 270012274 | BEACOPP |
| 270012722 | 270019882 | 1.7 | 59.6 | Curative (C) | 2016-12-09 | 2017-02-17 | Escalated BEACOPP | N | N | 270012274 | BEACOPP |
| 270012723 | 270008248 | 0 | 50.2 | Curative (C) | 2016-07-28 | 2016-07-28 | HD EuroNet-PHL-C1 COPDAC | 01 | null | 270012280 | TRIAL |
| 270012724 | 270008249 | 1.88 | 77.25 | Curative (C) | 2015-10-08 | 2015-10-10 | COPP + Dacarbazine | N | N | 270012284 | COPP + DACARBAZINE |
| 270012725 | 270008250 | 0 | 59.6 | Curative (C) | 2014-02-18 | 2014-02-18 | COPP + Dacarbazine | N | N | 270012285 | COPP + DACARBAZINE |
| 270012726 | 270008252 | 1.66 | 45.2 | Curative (C) | null | 2017-03-10 | Cetuximab 14 day | 02 | N | 270012286 | CETUXIMAB |
| 270012727 | 270008253 | 1.77 | 101.3 | Disease modification (D) | 2013-08-12 | 2013-10-13 | HD EuroNet-PHL-C1 COPDAC | 02 | N | 270012289 | TRIAL |
| 270012728 | 270008255 | null | 78.8 | Curative (C) | 2015-05-16 | 2015-11-02 | CETUXIMAB | 02 | N | 270012290 | CETUXIMAB |
| 270012729 | 270008258 | 1.8 | null | Curative (C) | 2017-09-09 | 2017-10-07 | CETUXIMAB | 2 | N | 270012300 | CETUXIMAB |
| 270012730 | 270013920 | 1.67 | null | Curative (C) | 2015-06-03 | 2015-06-10 | Escalated BEACOPP | 1 | N | 270012302 | BEACOPP |
| 270012731 | 270008261 | 0 | 79 | Curative (C) | 2015-08-02 | 2015-10-04 | COPP + Dacarbazine | N | N | 270012303 | COPP + DACARBAZINE |
| 270012732 | 270008264 | 1.76 | null | Curative (C) | 2016-05-27 | 2016-07-27 | HD EuroNet-PHL-C1 COPDAC | 2 | N | 270012303 | TRIAL |
| 270012733 | 270008265 | 1.63 | 72.2 | Curative (C) | 2014-12-26 | 2014-12-27 | HD EuroNet-PHL-C1 COPDAC | null | N | 270012310 | TRIAL |
| 270012734 | 270008269 | 1.75 | 96 | Curative (C) | 2015-08-15 | 2015-08-15 | COPP + Dacarbazine | null | null | 270012315 | COPP + DACARBAZINE |
| 270012735 | 270013923 | 1.69 | 74 | Curative (C) | 2016-10-02 | 2016-10-02 | CETUXIMAB | null | N | 270012317 | CETUXIMAB |
| 270012736 | 270008270 | 1.77 | 118 | null | null | 2013-12-21 | BEACOPP | N | null | 270012323 | BEACOPP |
| 270012737 | 270008272 | 1.86 | null | Curative (C) | 2014-07-11 | 2014-12-30 | Cetuximab 14 day | 02 | N | 270012331 | CETUXIMAB |
| 270012738 | 270008274 | 0 | null | Curative (C) | 2014-10-29 | 2015-01-01 | HD EuroNet-PHL-C1 Relapsed IEP | Y | N | 270012334 | TRIAL |
| 270012739 | 270008276 | 1.52 | 58 | null | 2013-01-09 | 2013-01-16 | Escalated BEACOPP | 02 | N | 270012336 | BEACOPP |
| 270012740 | 270008277 | 0 | 60.5 | Curative (C) | 2014-08-25 | 2014-08-25 | Trial Unspecified | N | N | 270012339 | TRIAL |
| 270012741 | 270008277 | 1.7 | 94.2 | Curative (C) | 2013-06-06 | 2013-06-06 | BEACOPP-14 | N | N | 270012339 | BEACOPP |
| 270012742 | 270008279 | 1.8 | 62 | Curative (C) | 2016-06-26 | 2017-01-11 | CETUXIMAB | N | null | 270012345 | CETUXIMAB |
| 270012743 | 270013929 | null | 52.3 | Curative (C) | null | 2018-03-19 | HD EuroNet-PHL-C1 COPDAC | N | null | 270012347 | TRIAL |
| 270012744 | 270013929 | 1.64 | 50 | Curative (C) | 2014-12-15 | 2014-12-16 | BEACOPP-14 | N | N | 270012347 | BEACOPP |
| 270012745 | 270019086 | 1.73 | 21.2 | Curative (C) | 2015-02-06 | 2015-05-01 | BEACOPP-14 | N | N | 270012357 | BEACOPP |
| 270012746 | 270008282 | 1.85 | 71.2 | Curative (C) | 2016-11-15 | 2016-11-19 | Trial Unspecified | 01 | N | 270012357 | TRIAL |
| 270012747 | 270008283 | 1.42 | 51.8 | Curative (C) | 2017-05-14 | 2017-07-13 | COPP + Dacarbazine | N | N | 270012363 | COPP + DACARBAZINE |
| 270012748 | 270008285 | 0 | 50.2 | Curative (C) | null | 2013-04-03 | COPP + Dacarbazine | 02 | Y | 270012368 | COPP + DACARBAZINE |
| 270012749 | 270008287 | 0 | 31.2 | Curative (C) | 2015-05-22 | 2015-05-23 | COPP + Dacarbazine | 2 | N | 270012371 | COPP + DACARBAZINE |
| 270012750 | 270008287 | 1.78 | 51 | Curative (C) | 2015-11-12 | 2016-02-03 | Escalated BEACOPP | 02 | N | 270012371 | BEACOPP |
| 270012751 | 270008287 | 1.57 | 48.7 | Curative (C) | 2016-06-30 | 2016-07-23 | Cetuximab 14 day | N | N | 270012371 | CETUXIMAB |
| 270012752 | 270008288 | 1.72 | 49.1 | Curative (C) | 2017-12-20 | 2017-12-27 | Cetuximab 14 day | N | N | 270012379 | CETUXIMAB |
| 270012753 | 270008289 | null | 85 | Curative (C) | 2016-11-20 | 2016-11-24 | Cetuximab 7 day (>Cycle 2) | N | null | 270012379 | CETUXIMAB |
| 270012754 | 270008290 | 1.8 | 61.1 | Curative (C) | 2014-05-24 | 2014-06-19 | CETUXIMAB | N | null | 270012381 | CETUXIMAB |
| 270012755 | 270008292 | 0 | 64 | Curative (C) | 2016-04-20 | 2016-06-26 | COPP + Dacarbazine | 02 | N | 270012387 | COPP + DACARBAZINE |
| 270012756 | 270008292 | 1.8 | 65 | Curative (C) | 2014-01-31 | 2014-01-31 | BEACOPP-14 | 2 | null | 270012387 | BEACOPP |
| 270012757 | 270016629 | 1.76 | 37.7 | Palliative (P) | 2018-02-05 | 2018-02-09 | CETUXIMAB | N | N | 270012391 | CETUXIMAB |
| 270012758 | 270008295 | 1.72 | 62.3 | null | 2015-05-17 | 2015-05-27 | BEACOPP | null | N | 270012396 | BEACOPP |
| 270012759 | 270008296 | 1.75 | 71 | Curative (C) | 2013-04-16 | 2013-05-14 | COPP + Dacarbazine | 02 | N | 270012397 | COPP + DACARBAZINE |
| 270012760 | 270008297 | 0 | 64.5 | Disease modification (D) | 2017-04-29 | 2017-05-05 | Trial Unspecified | Y | null | 270012399 | TRIAL |
| 270012761 | 270008297 | 1.64 | null | Curative (C) | 2013-07-06 | 2013-07-13 | BEACOPP | 2 | null | 270012399 | BEACOPP |
| 270012762 | 270016630 | null | 50.4 | Curative (C) | 2016-01-27 | 2016-03-31 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270012416 | CETUXIMAB |
| 270012763 | 270008298 | 0 | 51.8 | Curative (C) | 2018-03-23 | 2018-03-23 | COPP + Dacarbazine | 02 | N | 270012416 | COPP + DACARBAZINE |
| 270012764 | 270008298 | 1.75 | 98.5 | Curative (C) | 2017-04-06 | 2017-04-07 | CETUXIMAB | N | N | 270012416 | CETUXIMAB |